Add to My Stocks
$23.95 $0.68 (2.76%) DOVA stock closing price Sep 21, 2018 (Closing)

The financial analysis of DOVA requires an investor to check the cash flows for DOVA PHARMACUET. Financials statements like the DOVA PHARMACUET income statement and DOVA PHARMACUET balance sheet show that the company has profits and debt, while the cash flow statement provides details of cash flow movments. DOVA PHARMACUET cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. DOVA PHARMACUET had cash and cash equivalents of $28.7M at the beginning of the year and $94.84M at year end for 2017. DOVA PHARMACUET has a positive cash and cash equivalents change of $66.13M.

View details of DOVA PHARMACUET cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec20172016
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow--
Net Increase (Decrease) in Assets Liabilities1.94M7.56M
Cash From (used in) Discontinued Operations--
Other Adjustments Net17.11M18.64M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.06M-
Acquisition Disposition of Subsidiaires--
Increase (Decrease) in Investments--
Other Cash Inflow (Outflow) from Investment Activities-1M-
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares-29M
Issuance (Repayment) of Debt Securities--
Increase (Decrease) in Bank & Other Borrowings--
Payment of Dividends & Other Cash Distributions--
Other Cash from (used by) Financing Activities77.99M-
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash--
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year28.7M-
Cash & Equivalents at Year End94.84M28.7M
All figures in USD. M: Millions of USD, B: Billions of USD.

While DOVA PHARMACUET stock price history provides the price history of a stock, DOVA PHARMACUET stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that DOVA PHARMACUET is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - DOVA PHARMACUET stock price movement.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. DOVA PHARMACUET lost $-10.89M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash from investing stood at a negative value of $-1.06M for DOVA stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. DOVA PHARMACUET earned $78.09M from financing activities, in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For DOVA PHARMACUET Cash Flow

Annual Cash Flow Statements For DOVA PHARMACUET Peers

CONSORT MED ADR cash flow, Durata Therapeutics cash flow, Sagent Pharma cash flow